Barry E. Greene, Director at Karyopharm Therapeutics Inc. (KPTI), bought 3,000 shares at $29.31 ($88K) on 2015-04-02, disclosed to the SEC on 2015-04-06.
Open-market purchase of $88k KPTI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |